Efficacy of osimertinib against EGFRvIII+ glioblastoma.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC, Ballman KV, Ramakrishna R, Cross DA, Markert JM, Lim M, Gilbert MR, Lesser GJ, Kwatra MM.
Chagoya G, et al. Among authors: ballman kv.
Oncotarget. 2020 Jun 2;11(22):2074-2082. doi: 10.18632/oncotarget.27599. eCollection 2020 Jun 2.
Oncotarget. 2020.
PMID: 32547705
Free PMC article.